Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Brüggemann, R.J.M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(8)
+
-
Availability
Open access
(9)
+
-
Creation Date
2019
(3)
+
-
2020
(3)
+
-
2024
(2)
+
-
Faculty
Faculty of Science
(7)
+
-
Collection
Leiden Academic Centre for Drug Research (LACDR)
(7)
+
-
Scholarly Publications
(2)
+
-
Topic
Obesity
(2)
+
-
Pharmacokinetics
(2)
+
-
Author
Brüggemann, R.J.M.
(9)
+
-
Knibbe, C.A.J.
(9)
+
-
Wasmann, R.E.
(6)
+
-
Smit, C.
(5)
+
-
Dongen, E.P.A. van
(3)
+
-
Linden, P.D. van der
(3)
+
-
Mouton, J.W.
(3)
+
-
Rhee, K.P. van
(3)
+
-
Burger, D.M.
(2)
+
-
Goulooze, S.C.
(2)
+
-
Krekels, E.H.J.
(2)
+
-
Verweij, P.E.
(2)
+
-
Wiezer, R.M.J.
(2)
+
-
Show more
Language
en
(9)
+
-
Search results
(1 - 9 of 9)
show grid
show list
save search
Patients with obesity should be recognised as a special patient population during drug development of antibacterial and antifungal agents
Pooled population pharmacokinetic analysis and dose recommendations for ciprofloxacin in intensive care unit patients with obesity
Ciprofloxacin pharmacokinetics after oral and intravenous administration in (morbidly) obese and non-obese individuals
Implications for IV posaconazole dosing in the era of obesity
Correction to: Tobramycin clearance is best described by renal function estimates in obese and nonobese Individuals: results of a prospective rich sampling pharmacokinetic study
Pharmacokinetics and pharmacodynamics of posaconazole
Population pharmacokinetics of vancomycin in obesity: finding the optimal dose for (morbidly) obese individuals
A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients
Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults